Pharma Capital
Market: AIM
52-week High/Low:
Sector: Pharma & Biotech
Market Cap: 2,223.07M
Phone: +44 (0)1980 557 000
Address: Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ.

GW Pharmaceuticals was founded in 1998 and listed on AIM, a market of the London Stock Exchange, in June 2001. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a product portfolio of cannabinoid prescription medicines, including Sativex® Oromucosal Spray, to meet patient needs in a wide range of therapeutic indications...

GW Pharmaceuticals is traded in the ISDX Exchange HERE

GW Pharmaceuticals

Interactive graph

col 3
col 4
col 5
col 6

GW Pharmaceuticals Timeline

View All

Market Reports Including GWP


Executive video interviews


© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.